US 6,982,079 B2 | ||
Compositions for treating hyperemia | ||
Stanley W. Huth, Newport Beach, Calif. (US) | ||
Assigned to Allergan, Inc., Irvine, Calif. (US) | ||
Filed on Apr. 26, 2002, as Appl. No. 10/133,094. | ||
Prior Publication US 2003/0203034 A1, Oct. 30, 2003 | ||
Int. Cl. A61K 31/74 (2006.01); A61K 47/30 (2006.01) |
U.S. Cl. 424—78.04 | 17 Claims |
1. A composition comprising:
an ophthalmically acceptable carrier component;
a vasoconstrictor component in an amount effective to treat hyperemia when the composition is administered to an eye; and
a polyanionic component in an amount effective to provide lubrication to an eye when the composition is administered to an
eye, the composition being a solution.
|